Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00716534 · COMPLETED
Trial details
- NCT number
- NCT00716534
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2012-04-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.